Ni Liang Selected Research

notoginsenoside R2

12/2021

Notoginsenoside R2 reduces Aβ25-35-induced neuronal apoptosis and inflammation via miR-27a/SOX8/β-catenin axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ni Liang Research Topics

Disease

1	Ischemic Stroke 01/2023
1	Thrombosis (Thrombus) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Disseminated Intravascular Coagulation 01/2022
1	Stroke (Strokes) 12/2021
1	Hypoxia (Hypoxemia) 12/2021
1	Necrosis 12/2021
1	Inflammation (Inflammations) 12/2021
1	Neuroinflammatory Diseases 12/2021
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Lentivirus Infections 01/2021
1	AIDS-Related Complex (ARC) 01/2019
1	Folliculitis (Sycosis) 02/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017

Drug/Important Bio-Agent (IBA)

1	C-Reactive ProteinIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	EndotoxinsIBA 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	FibrinIBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	notoginsenoside R2IBA 12/2021
1	CateninsIBA 12/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	dectin 1IBA 02/2018
1	InflammasomesIBA 02/2018
1	LipidsIBA 01/2017

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2021